Adapt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAPT, and what generic and branded alternatives to ADAPT drugs are available?
ADAPT has five approved drugs.
Summary for Adapt
US Patents: | 0 |
Tradenames: | 5 |
Ingredients: | 5 |
NDAs: | 5 |
Patent Litigation for Adapt: | See patent lawsuits for Adapt |
Drugs and US Patents for Adapt
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adaptis | VALACYCLOVIR HYDROCHLORIDE | valacyclovir hydrochloride | TABLET;ORAL | 079012-001 | May 24, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-001 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adapt | NARCAN | naloxone hydrochloride | INJECTABLE;INJECTION | 016636-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-006 | Jul 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adapt | NARCAN | naloxone hydrochloride | INJECTABLE;INJECTION | 016636-003 | Jun 14, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ADAPT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Nasal Spray | 4 mg/spray | ➤ Subscribe | 2016-07-15 |